Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-10-07
1996-11-26
Rollins, John W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514211, 514 50, 514456, 514731, 514736, 424649, A61K 31545, A61K 3155, A61K 3170, A61K 3135
Patent
active
055785905
ABSTRACT:
The present invention provides a method of inhibiting protein kinase C in a mammal having a tumor system which contains protein kinase C, which mammal is undergoing cytostatic therapy. The method comprises administering to the mammal a protein kinase C inhibitor.
REFERENCES:
Chemical Abstracts 107:70385 f (1987).
Chemical Abstracts 108:31509 a (1988).
The Merck Index, 10th ED, Merck and Co., Inc, 1983, Rahway, N.J. p. 329.
Hofmann et al, J of Cancer, International, vol. 42, No. 3, pp. 382-388, Sep. 15, 1988.
Hofmann et al. "Synergistic Enhancement of the Antiproliferative Activity of cis-Diamminedichloroplatinum(II) by the Ether Lipid Analogue BM 41.440, an Inhibitor of Protein Kinase C". Lipids, 1989, 24, 312.
Hofmann et al. "Enhancement of the Antiproliferative Effect of cis-Ciamminedichloroplatinium(II) and Nitrogen Mustard by Inhibitors of Protein Kinase C". Int. J. Cancer, 1988, 42, 382.
Palayoor et al. "Inhibition of Protein Kinase C by Antineoplastic Agents: Implications for Drug Resistance". Biochem. Biophys. Res. Commun., 1987, 148, 718.
Ido et al. "An Inhibitor of Protein Kinase C, 1-(5-Isoquinolinylsulfonyl)-2-Methylpiperazine (H-7) Inhibits TPA-Induced Reduction of Vincristine Uptake from P388 Murine Leukemic Cell". Leukemia Res. 1986, 10, 1063.
Laubenstein et al. "Treatment of Epidemic Kaposi's Sarcoma with Etoposide or a Combination of Doxorubicin, Bleomycin and Vinblastine". J. Clin. Oncol., 1984, 2, 1115.
Kaplan et al. "Treatment of Kaposi's Sarcoma in Acquired Immunodeficiency Syndrome with an Alternating Vincristine-Vinblastine Regimen". Cancer Treat. Rep., 1986, 70, 1121.
Giaccone et al. "Mitomycin C, Vinblastine and cis-platin. An Active Regimen for Advanced Non-Small Cell Lung Cancer". brit. J. Cancer, 1987, 56, 475.
Olweny et al. "Treatment of Kaposi's Sarcoma by Combination of Actinomycin-D, Vincristine and Imidazole Carboxamide (NSC-45388): Results of a Randomized Clinical Trial". Int. J. Cancer, 1974, 14, 649.
Nathanson et al. "Vinblastine, Infusion, Bleomycin and cis-Dichlorodiammine-Platinum Chemotherapy in Metastic Melanoma". Cancer, 1981, 1981, 48, 1290.
Chahinian et al. "MACC(Methotrexate, Adriamycin, Cyclophosphamide and CCNU) in Advanced Lung Cancer". Cancer, 1979, 43, 1590.
Buyukpamakcu et al. "Combined Chemotherapy in 76 Children with Non-Hodgkin's Lymphoma Excluding Burkitt's Lymphoma". Br. J. Cancer, 1987, 56, 625.
Corbett et al. "Biology and Therapeutic Response of Mouse Mammary Adenocarcinoma (16/C) and its Potential as a Model for Surgical Adjuvant Chemotherapy". Cancer Treat. Rep., 1978, 62, 1471.
Wallach et al. "Chemotherapy of Recurrent Ovarian Carcinoma with cis-Dichlorodiammine Platinum II and Adriamycin". Obstet. Gynecol., 1980, 55, 371.
Anderson et al. "Childhood Non-Hodgkin's Lymphoma. The Results of Randomized Therapeutic Trial Comparing a 4-Drug Regimen (COMP) with a 10-Drug Regimen (LSA.sub.2 -L.sub.2 )". New Eng. J. Med., 1983, 308, 559.
Vogel et al. "Treatment of Kaposi's Sarcoma with a Combination of Actinomycin D and Vincristine". Cancer, 1973, 31, 1382.
Cohen et al. "Combination Chemotherapy of Malignant Melanoma with Imidazole Carboxamide, BCNU and Vincristine". Cancer, 1977, 39, 41.
Bailey et al. "Chemotherapy of Human Breast-Carcinoma Xenografts". Br. J. Cancer, Treat. Rep., 1976, 60, 1273.
DeWasch et al. "Combination Chemotherapy with Three Marginally Effective Agents, CCNU, Vincristine and Bleomycin, in the Treatment of Stage III Melanoma". Cancer Treat. Rep., 1976, 60, 1273.
Holland et al. "Cisplatin Therapy of Ovarian Cancer". in Cisplatin, 1980, Academic Press, p. 383-391.
Nathanson et al. "Pilot Study of Vinblastine and Bleomycin Combinations in the Treatment of Metastatic Melanoma". Cancer Treat. Rep., 1983, 67, 943.
Schulman et al. "Phase II Trial of Mitomycin, Vinblastine and Cisplatin MVP) in Non-Small Cell Bronchogenic Carcinoma". Cancer, 1983, 67, 943.
Mabel et al. "Combination Chemotherapy Against B16 Melanoma: Bleomycin/Vinblastine, Bleomycin/ Cis-Diamminedichloroplatinium, 5-Fluorouracil/BCNU and 5-Fluorouracil/Methyl-CCNU". Cancer, 1978, 42, 1711.
Samuels et al. "Bleomycin Combination Chemotherapy in the Management of Testicular Neoplasias". Int. J. Cancer, 1975, 36, 318.
Ettinger et al. "Adriamycin (ADR) and cis-Diamminedichloroplatinum (DDP) as Adjuvant Therapy in Osteosarcoma of the Extremities". Int. J. Cancer, 1975, 36, 318.
Pendergrass et al. "Intensive Timed Sequential Combination Chemotherapy and Adjunctive Radiotherapy in Extensive Stage Small Cell Carcinoma of the Lung (SCC)". Proc. Amer. Assoc. Cancer Res. and ASCO, 1980, Abstract C-505.
Mason et al. "Mitomycin (M), Vinblastine (V) and Cisplatin (P) Combination Chemotherapy in Non-Small Cell Lung Cancer (NSCLC)". Proc. Amer. Assoc. Cancer Res. and ASCO, 1980, Abstract C-507.
Livingston et al. "BACON (Bleomycin, Adriamycin, CCNU, Oncovin and Nitrogen Mustard) in Squamous Lung Cancer". Cancer, 1976, 37, 1237.
Vogel et al. "Combination Chemotherapy with Adriamycin and Cis-Diamminedichloroplatinum in Patients with Neoplastic Diseases". Cancer, 1976, 38, 21.
Bitran et al. "Cyclophosphamide, Adriamycin, Methotrexate and Procarbazine (CAMP)-Effective Four-Drug Combination Chemotherapy for Metastatic Non-Oat Cell Bronchogenic Carcinoma". Cancer Treat. Rep., 1976, 60, 1225.
Okazaki et al. "Staurosporine, a Novel Protein Kinase Inhibitor, Enhances HL-60-cell Differentiation Induced by Various Compounds". Exp. Hematol., 1988, 16, 42.
Britell et al. "cis-Dichlorodiammineplatinum(II) Alone Followed by Adriamycin Plus Cyclophosphamide at Progression Versus cis-Dichlorodiammineplatinum(II), Adriamycin and Cyclophosphamide for Adenocarcinoma of the Lung". Cancer Treat. Rep., 1978, 62, 1207.
Bruckner et al. "Combination Chemotherapy of Ovarian Carcinoma with Cyclophosphamide, Adriamycin and cis-Dichlorodiammineplatinum(II) After Failure of Initial Chemotherapy". Cancer Treat. Rep., 1978, 62, 1021.
Spigel et al. "Vinblastine (NSC-49842) and Bleomycin (NSC-125066) Therapy for Disseminated Testicular Tumors". Cancer Chemotherapy Rep., 1974, 58, 213.
Moertel et al. "Brief Communication: Therapy of Advanced Colorectal Cancer with a Combination of 5-Fluorouracil, Methyl-1,3-cis(2-chlorethyl)-1-nitrosourea and Vincristine)". J. Natl. Cancer Inst., 1975, 54, 69.
Livingston et al. "Kinetic Scheduling of Vincristine (NSC-67574) and Bleomycin (NSC-125066) in Patients with Lung Cancer and Other Malignant Tumors". Cancer Chemotherapy Rep., 1973, 57, 219.
Einhorn et al. "Combination Chemotherapy of Disseminated Testicular Carcinoma with cis-Platinum Diammine Dichloride (CPDD), Vinblastine (VLB) and Bleomycin (BLEO)". Proc Amer. Assoc. Cancer Res., 1976, 17, 240, Abstract C-13.
Holoye et al. "Cytoxan, Adriamycin and Vincristine Combination with Radiation Therapy in the Treatment of Small Cell Carcinoma of the Lung". Proc. Amer. Assoc. Cancer Res., 1975, 16, 112, Abstract 447.
Eagan et al. "Cytoxan (CTX), Adriamycin (ADR) and Cis-Platinum (CDDP) Infusion (CAP-II) in Patients with Advanced Large Cell (LGC) Lung Cancer". Proc. Amer. Assoc. Cancer Res., 1978, Abstract 181.
Vogl et al. "Cyclophosphamide (C), Hexamethylmelamine (H), Adriamycin (A) & Diamminedichloroplatinum (D) as Initial Chemotherapy for Advanced Ovarian Cancer". Proc. Amer. Soc. Clin. Oncol., 1975, Abstract 1205.
Ohnuma et al. "Adriamycin (ADM) and Diamminedichloroplatinum (DDP) in Combination".Proc. Amer. Soc. Clin. Oncol., 1976, Abstract C-203.
Chahinian et al. "Chemotherapy of Bronchogenic Carcinoma with Methotrexate (MTX), Adriamycin (ADM), Cyclophosphamide (CYT) and CCNU". Proc. Amer. Soc. Clin. Oncol., 1976, Abstract C-204.
Bruckner et al. "Chemotherapy of Ovarian Cancer with Adriamiyin (ADM) and Cis-Platinum (DDP)". Proc. Amer. Assoc. Cancer Res., 1978, Abstract 642.
Troner et al. "Cyclophosphamide, Adriamycin and Cis-Platinum (CAP) Chemotherapy of Metastatic Transitional Cell Carcinoma (TCC) of the Bladder". Proc. Amer. Assoc. Cancer Res., 1978, Abstract 642.
Parker et al. "Adriamycin-Cyclophosphamide Therapy Therapy in Ovarian Cancer". Proc. Amer. Soc. Clin. Oncol., 1975, Abstract 1171.
Herman et al. "
Bosies Elmar
Grunicke Hans H.
Herrmann Dieter
Hofmann Johann
Boehringer Mannheim GmbH
Rollins John W.
LandOfFree
Pharmaceutical composition preparation for use in inhibiting pro does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition preparation for use in inhibiting pro, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition preparation for use in inhibiting pro will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1973255